Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-09

Clinical Trial Update: Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating itopride hydrochloride for effects on gastric emptying and glycemic control in diabetes-associated gastroparesis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Itopride hydrochloride (itopride hydrochloride)

Snippet

Sponsor: Forest Laboratories | Conditions: Gastroparesis | Phase 1, Phase 2 | Status: COMPLETED